Expanding ODF Applications: From Oral Films to Transdermal and Cosmetic Patches

Introduction
ODF (Oral Dissolvable Film) technology is no longer confined to oral dissolving applications. It's rapidly expanding into transdermal patches, oral care films, and functional food products. This “patch-like” trend is unlocking larger market potential — but for companies targeting both supplement and pharmaceutical sectors, choosing GMP-compliant equipment from the start is critical to avoid costly upgrades later on.

1. Market Drivers Behind the Patch-Like Trend

• Differentiated Dosage Forms: Suited for niche applications and emerging health markets
• Consumer Upgrades: Beauty, pet care, and sports recovery favor fast-absorbing formats
• Social Media Friendly: Innovative dosage formats generate buzz on short video platforms

2. Cross-Sector Application Scenarios

• Transdermal Patches: For pain relief, fever reduction — requiring even distribution and skin adhesion
• Oral Care Films: Whitening and antibacterial films with food- or pharma-grade safety
• Functional Food Films: Caffeine or probiotic films for quick, convenient absorption

3. HUANGHAI’s Cross-Sector Capabilities

• Offers a full suite of food-grade, supplement-grade, and pharma-grade equipment configurations
• All machines designed to meet GMP standards, ready for regulatory review and global registration
• Integrated coating, drying, cutting, and packaging systems — with models like the MJ150-L for R&D, and MJF180 for cleanroom packaging

Conclusion

The integration of ODF and patch technologies is unlocking new product categories. Companies equipped with GMP-ready machinery will have a significant advantage in global competition. HUANGHAI stands ready to support the next generation of high-value, cross-sector ODF products.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

*Designed to meet Class I Div 1 / ATEX explosion-proof standards for safe transdermal solvent handling.

---

Frequently Asked Questions

Q: What is the difference between an ODF film and a transdermal patch?

A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ODF machine?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ODF production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.

Q: What are the GMP requirements for ODF production equipment?

A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.

Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?

A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.

For details on our IQ/OQ/PQ certification suite and FDA compliance credentials, see our Certifications & Compliance page.